LPL Financial’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,051
Closed -$61.6K 5518
2025
Q1
$61.6K Sell
4,051
-22
-0.5% -$335 ﹤0.01% 4995
2024
Q4
$74.8K Sell
4,073
-67
-2% -$1.23K ﹤0.01% 4926
2024
Q3
$45.9K Sell
4,140
-60
-1% -$665 ﹤0.01% 4903
2024
Q2
$39K Buy
4,200
+12
+0.3% +$111 ﹤0.01% 4769
2024
Q1
$137K Sell
4,188
-132
-3% -$4.32K ﹤0.01% 4531
2023
Q4
$116K Sell
4,320
-487
-10% -$13K ﹤0.01% 4460
2023
Q3
$291K Sell
4,807
-3
-0.1% -$181 ﹤0.01% 3904
2023
Q2
$490K Sell
4,810
-47
-1% -$4.79K ﹤0.01% 3430
2023
Q1
$859K Sell
4,857
-28
-0.6% -$4.95K ﹤0.01% 2853
2022
Q4
$1.89M Sell
4,885
-62
-1% -$24K ﹤0.01% 2107
2022
Q3
$1.67M Buy
4,947
+247
+5% +$83.2K ﹤0.01% 2117
2022
Q2
$1.55M Buy
4,700
+285
+6% +$93.7K ﹤0.01% 2223
2022
Q1
$1.93M Sell
4,415
-21
-0.5% -$9.19K ﹤0.01% 2078
2021
Q4
$1.95M Sell
4,436
-211
-5% -$92.5K ﹤0.01% 2107
2021
Q3
$2.59M Buy
4,647
+282
+6% +$157K ﹤0.01% 1854
2021
Q2
$2.24M Buy
4,365
+221
+5% +$114K ﹤0.01% 1879
2021
Q1
$3.24M Sell
4,144
-24
-0.6% -$18.8K ﹤0.01% 1515
2020
Q4
$2.27M Buy
4,168
+14
+0.3% +$7.63K ﹤0.01% 1591
2020
Q3
$1.9M Sell
4,154
-60
-1% -$27.5K ﹤0.01% 1484
2020
Q2
$2.59M Buy
4,214
+73
+2% +$44.9K ﹤0.01% 1211
2020
Q1
$1.97M Buy
4,141
+19
+0.5% +$9.03K ﹤0.01% 1199
2019
Q4
$2.39M Buy
4,122
+332
+9% +$193K ﹤0.01% 1236
2019
Q3
$2.49M Sell
3,790
-15
-0.4% -$9.87K 0.01% 1118
2019
Q2
$2.95M Buy
3,805
+221
+6% +$171K 0.01% 1028
2019
Q1
$2.53M Buy
3,584
+220
+7% +$155K 0.01% 1062
2018
Q4
$1.57M Sell
3,364
-13
-0.4% -$6.08K ﹤0.01% 1205
2018
Q3
$2.91M Sell
3,377
-24
-0.7% -$20.7K 0.01% 964
2018
Q2
$2.34M Buy
3,401
+274
+9% +$189K 0.01% 1033
2018
Q1
$1.39M Buy
3,127
+1,065
+52% +$475K ﹤0.01% 1350
2017
Q4
$909K Buy
2,062
+502
+32% +$221K ﹤0.01% 1582
2017
Q3
$769K Sell
1,560
-72
-4% -$35.5K ﹤0.01% 1619
2017
Q2
$904K Buy
1,632
+884
+118% +$490K ﹤0.01% 1434
2017
Q1
$482K Buy
+748
New +$482K ﹤0.01% 1833